ArticleBreast cancer (Tokyo, Japan)2017

Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells.

Angelika Kaczyńska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.